CNDO Insider Trading Activity and SEC Form 4 Filings
CNDO insider trading summary
No open-market insider purchases or sales of Coronado Biosciences Inc (CNDO) have been reported on SEC Form 4 in the past 12 months.
Latest CNDO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 1, 2014 | Lucy Lu | Chief Financial Officer | Buy | $7K (5,000 @ $1.45) |
| Dec 1, 2014 | Lindsay A Md Rosenwald | President and CEO | Buy | $1K (974 @ $1.45) |
| Nov 6, 2014 | Malcolm Hoenlein | Director | Buy | $40K (25,000 @ $1.61) |
| Nov 6, 2014 | Lindsay A Md Rosenwald | President and CEO | Buy | $242K (150,000 @ $1.61) |
| Nov 6, 2014 | Michael S Weiss | Exec. VC - Strategic Dev. | Buy | $1.6M (1,000,000 @ $1.61) |
| Jun 2, 2014 | Lucy Lu | Chief Financial Officer | Buy | $7K (5,000 @ $1.37) |
| Apr 22, 2014 | Kevin Horgan | Insider | Sell | $90K (47,566 @ $1.89) |
| Apr 21, 2014 | Kevin Horgan | Insider | Sell | $34K (19,000 @ $1.81) |
| Apr 17, 2014 | Kevin Horgan | Insider | Sell | $187 (101 @ $1.85) |
| Dec 4, 2013 | Lucy Lu | Chief Financial Officer | Buy | $2K (1,107 @ $1.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.